News
StockStory.org on MSN11d
10x Genomics’s (NASDAQ:TXG) Q1: Strong Sales But Quarterly Revenue Guidance Significantly Misses ExpectationsBiotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results , with sales up 9.8% year on year to $154.9 million. On ...
Genomics (NASDAQ:TXG) is scheduled to announce Q1 earnings results on Thursday, May 8th, after market close. The consensus ...
As you might know, 10x Genomics, Inc. (NASDAQ:TXG) just kicked off its latest quarterly results with some very strong numbers. The results overall were pretty good, with revenues of US$155m ...
PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $34.4 million in its first quarter. The Pleasanton, California-based company said it had a ...
PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $34.4 million in its first quarter. The Pleasanton, California-based company said it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback